Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating costs and expenses
General and administrative	$ 3,833	$ 1,787
Research and development	1	2,016
Total operating expenses	3,834	3,803
Loss from operations	(3,834)	(3,803)
Other (expenses) income
Other income		64
Interest income	137	179
Loss on marketable securities	(65)	(497)
Change in fair value of investments		522
Total other (expenses) income	72	268
Net loss	(3,762)	(3,535)
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock		(3,009)
Net Loss Attributable to Common Shareholders	$ (3,762)	$ (6,544)
Net loss per share, basic and diluted
Basic (in Dollars per share)	$ (0.71)	$ (1.25)
Weighted average number of shares outstanding, basic and diluted
Basic (in Shares)	5,305,513	5,252,517